These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 12803511)

  • 1. Recombinant erythropoietin in autoimmune hemolytic anemia with inadequate bone marrow response: a prospective analysis.
    Fattizzo B; Pedone GL; Brambilla C; Pettine L; Zaninoni A; Passamonti F; Barcellini W
    Blood Adv; 2024 Mar; 8(5):1322-1327. PubMed ID: 38029356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Controlled Study of Efficacy and Safety of Accelerated Versus Standard Hepatitis B Vaccination in Patients With Advanced CKD.
    Kittrakulrat J; Tiankanon K; Kerr SJ; Wattanatorn S; Udomkarnjananun S; Tungsanga S; Chaiteerakij R; Praditpornsilpa K; Eiam-Ong S; Avihingsanon Y; Tiranathanagul K; Vanichanan J; Townamchai N
    Kidney Int Rep; 2024 Apr; 9(4):853-862. PubMed ID: 38770057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinome Analysis to Define Mechanisms of Adjuvant Action: PCEP Induces Unique Signaling at the Injection Site and Lymph Nodes.
    Awate S; Scruten E; Mutwiri G; Napper S
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Humoral Immune Response of the ChAdOx1 nCoV-19 Vaccine in Maintenance Dialysis Patients without Prior COVID-19 Infection.
    Cheng CY; Fang TC; Liao HW; Chen TH; Chang JH; Lin YC; Kao CC; Liu MC; Chang HW; Hung CS; Wang JC; Hsiao SH; Sue YM
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mercury Exposure and Poor Nutritional Status Reduce Response to Six Expanded Program on Immunization Vaccines in Children: An Observational Cohort Study of Communities Affected by Gold Mining in the Peruvian Amazon.
    Wyatt L; Permar SR; Ortiz E; Berky A; Woods CW; Amouou GF; Itell H; Hsu-Kim H; Pan W
    Int J Environ Res Public Health; 2019 Feb; 16(4):. PubMed ID: 30795575
    [No Abstract]   [Full Text] [Related]  

  • 6. Dendritic Cell Dysfunction in Patients with End-stage Renal Disease.
    Kim JU; Kim M; Kim S; Nguyen TT; Kim E; Lee S; Kim S; Kim H
    Immune Netw; 2017 Jun; 17(3):152-162. PubMed ID: 28680376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levamisole usage as an adjuvant to hepatitis B vaccine in hemodialysis patients, yes or no?
    Sanadgol H
    Nephrourol Mon; 2013; 5(1):673-8. PubMed ID: 23577329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.
    Keating GM; Noble S
    Drugs; 2003; 63(10):1021-51. PubMed ID: 12699402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant hepatitis B vaccination in renal failure patients.
    Vlassopoulos D
    Curr Pharm Biotechnol; 2003 Apr; 4(2):141-51. PubMed ID: 12678888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of erythropoietin therapy and hemoglobin levels on the immune response to Engerix-B vaccination in chronic kidney disease.
    Hassan K; Shternberg L; Alhaj M; Giron R; Reshef R; Barak M; Kristal B
    Ren Fail; 2003 May; 25(3):471-8. PubMed ID: 12803511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
    Chow KM; Law MC; Leung CB; Szeto CC; Li PK
    Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Chaparro M; Gordillo J; Domènech E; Esteve M; Barreiro-de Acosta M; Villoria A; Iglesias-Flores E; Blasi M; Naves JE; Benítez O; Nieto L; Calvet X; García-Sánchez V; Villagrasa JR; Marin AC; Donday MG; Abad-Santos F; Gisbert JP
    Am J Gastroenterol; 2020 Nov; 115(11):1802-1811. PubMed ID: 33156099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination against hepatitis B in patients with chronic renal failure--twenty years follow-up].
    Roznovský L; Tvrdík J; Kabieszová L; Petrousová L; Orságová I; Hozáková L; Lochman I; Kloudová A; Valkovský I; Letocha P; Schwarzová S; Hladík M; Zjevíková A
    Vnitr Lek; 2011 Oct; 57(10):808-14. PubMed ID: 22097688
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.